Activation of Receptor Tyrosine Kinases Mediates Acquired Resistance to MEK Inhibition in Malignant Peripheral Nerve Sheath Tumors.

Cancer Research
Jiawan WangChristine A Pratilas

Abstract

Malignant peripheral nerve sheath tumors often arise in patients with neurofibromatosis type 1 and are among the most treatment-refractory types of sarcoma. Overall survival in patients with relapsed disease remains poor, and thus novel therapeutic approaches are needed. NF1 is essential for negative regulation of RAS activity and is altered in about 90% of malignant peripheral nerve sheath tumors (MPNST). A complex interplay of upstream signaling and parallel RAS-driven pathways characterizes NF1-driven tumorigenesis, and inhibiting more than one RAS effector pathway is therefore necessary. To devise potential combination therapeutic strategies, we identified actionable alterations in signaling that underlie adaptive and acquired resistance to MEK inhibitor (MEKi). Using a series of proteomic, biochemical, and genetic approaches in an in vitro model of MEKi resistance provided a rationale for combination therapies. HGF/MET signaling was elevated in the MEKi-resistant model. HGF overexpression conferred resistance to MEKi in parental cells. Depletion of HGF or MET restored sensitivity of MEKi-resistant cells to MEKi. Finally, a combination of MEK and MET inhibition demonstrated activity in models of MPNST and may therefore be e...Continue Reading

References

Feb 19, 2008·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Kiran K MantripragadaMeena Upadhyaya
May 24, 2008·Science·Yasemin SancakDavid M Sabatini
Nov 18, 2008·Cancer Research·Christine A PratilasDavid B Solit
Mar 3, 2009·Proceedings of the National Academy of Sciences of the United States of America·Christine A PratilasNeal Rosen
May 20, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Rashmi ChughLaurence H Baker
Dec 17, 2009·Journal of Neuropathology and Experimental Neurology·Robert M VerdijkJohan M Kros
Nov 26, 2010·Nature·Cory M JohannessenLevi A Garraway
May 5, 2011·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Keila E TorresDina Lev
Nov 2, 2011·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Jilong YangWei Zhang
Jun 12, 2012·Nature Medicine·Alex KentsisA Thomas Look
Dec 12, 2012·The Journal of Clinical Investigation·Walter J JessenNancy Ratner
Jan 5, 2013·Cancer Discovery·Steven R WhittakerLevi A Garraway
Feb 19, 2014·Cancer Discovery·Elza C de BruinJulian Downward
Jun 11, 2014·Cancer Discovery·Clare F MaloneKaren Cichowski
Oct 13, 2014·Nature Genetics·Ming ZhangChetan Bettegowda
Oct 26, 2014·Annals of Oncology : Official Journal of the European Society for Medical Oncology·A W TolcherJ R Infante
Mar 16, 2016·Leukemia·Lukasz P GondekChristopher D Gocke
Oct 18, 2016·International Journal of Oncology·Masato ChibaKazuto Nishio
Dec 29, 2016·The New England Journal of Medicine·Eva DombiBrigitte C Widemann
Feb 1, 2017·Molecular Cancer Therapeutics·Hanyin ChengAndrew E Aplin
Sep 2, 2017·Experimental Neurology·AeRang Kim, Christine A Pratilas
Jul 11, 2018·The Journal of Clinical Investigation·Jeffrey A KnaufJames A Fagin

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.